c-LEcta receives EXCiPACT certification: accolade for high quality standard

With the internationally recognised EXCiPACT certification, the globally successful biotech company c-LEcta GmbH from Leipzig receives confirmation of its high quality standards in production and distribution (GMP and GDP). The certificate is recognised worldwide by relevant authorities such as the European Union (EU), the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Authority (MHRA). EXCiPACT certification means more safety for patients, a reduction in the audit burden and improved transparency for all parties involved. More information: t1p.de

Also: What the artificial enzyme DENARASE from c-LEcta does in the production of Corona vaccines can be seen here in a video: vimeo.com